Wendy Stock to Ribonucleotide Reductases
This is a "connection" page, showing publications Wendy Stock has written about Ribonucleotide Reductases.
Connection Strength
0.009
-
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Am J Hematol. 1996 May; 52(1):42-6.
Score: 0.009